{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T05:38:21Z","timestamp":1784266701619,"version":"3.55.0"},"reference-count":30,"publisher":"Portland Press Ltd.","issue":"23","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,12,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>This Editorial, written by Guest Editors Professor Michael Bader, Professor Anthony J. Turner and Dr Natalia Alenina, proudly introduces the Clinical Science-themed collection on angiotensin-converting enzyme 2 (ACE2), a multifunctional protein \u2013 from cardiovascular regulation to coronavirus disease 2019 (COVID-19).<\/jats:p>","DOI":"10.1042\/cs20201493","type":"journal-article","created":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T17:31:42Z","timestamp":1607707902000},"page":"3229-3232","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["ACE2, a multifunctional protein \u2013 from cardiovascular regulation to COVID-19"],"prefix":"10.1042","volume":"134","author":[{"given":"Michael","family":"Bader","sequence":"first","affiliation":[{"name":"Max Delbru\u0308ck-Center for Molecular Medicine, Berlin, Germany"},{"name":"German Center for Cardiovascular Research (DZHK), Partner Site Berlin, Berlin, Germany"},{"name":"Charit\u00e9 University Medicine, Berlin, Germany"},{"name":"Institute for Biology, University of L\u00fcbeck, L\u00fcbeck, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8218-8198","authenticated-orcid":false,"given":"Anthony\u00a0J.","family":"Turner","sequence":"additional","affiliation":[{"name":"School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds LS2 9JT, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Alenina","sequence":"additional","affiliation":[{"name":"Max Delbru\u0308ck-Center for Molecular Medicine, Berlin, Germany"},{"name":"German Center for Cardiovascular Research (DZHK), Partner Site Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2020,12,11]]},"reference":[{"key":"2021113011181144200_B1","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1161\/01.RES.87.5.e1","article-title":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circ. Res."},{"key":"2021113011181144200_B2","doi-asserted-by":"publisher","first-page":"33238","DOI":"10.1074\/jbc.M002615200","article-title":"A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase","volume":"275","author":"Tipnis","year":"2000","journal-title":"J. Biol. Chem."},{"key":"2021113011181144200_B3","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"2021113011181144200_B4","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1042\/CS20200476","article-title":"Discovery and characterization of ACE2 - a 20-year journey of surprises from vasopeptidase to COVID-19","volume":"134","author":"Hooper","year":"2020","journal-title":"Clin. Sci. (Lond.)"},{"key":"2021113011181144200_B5","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1128\/JVI.02202-13","article-title":"TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein","volume":"88","author":"Heurich","year":"2014","journal-title":"J. Virol."},{"key":"2021113011181144200_B6","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1126\/science.abb2762","article-title":"Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2","volume":"367","author":"Yan","year":"2020","journal-title":"Science"},{"key":"2021113011181144200_B7","doi-asserted-by":"publisher","first-page":"L84","DOI":"10.1152\/ajplung.00071.2009","article-title":"Ectodomain shedding of angiotensin converting enzyme 2 in human airway epithelia","volume":"297","author":"Jia","year":"2009","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"2021113011181144200_B8","doi-asserted-by":"publisher","first-page":"3512","DOI":"10.1111\/j.1742-4658.2005.04756.x","article-title":"Identification of critical active-site residues in angiotensin-converting enzyme-2 (ACE2) by site-directed mutagenesis","volume":"272","author":"Guy","year":"2005","journal-title":"FEBS J."},{"key":"2021113011181144200_B9","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.chom.2020.08.004","article-title":"Virus-receptor interactions of glycosylated SARS-CoV-2 spike and human ACE2 receptor","volume":"28","author":"Zhao","year":"2020","journal-title":"Cell Host Microbe"},{"key":"2021113011181144200_B10","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.1007\/s00018-018-2815-y","article-title":"Depletion of angiotensin-converting enzyme 2 reduces brain serotonin and impairs the running-induced neurogenic response","volume":"75","author":"Klempin","year":"2018","journal-title":"Cell Mol. Life Sci."},{"key":"2021113011181144200_B11","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1042\/CS20200477","article-title":"ACE2 and gut amino acid transport","volume":"134","author":"Camargo","year":"2020","journal-title":"Clin. Sci. (Lond)"},{"key":"2021113011181144200_B12","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1042\/CS20200899","article-title":"ACE2 and ACE: structure-based insights into mechanism, regulation and receptor recognition by SARS-CoV","volume":"134","author":"Lubbe","year":"2020","journal-title":"Clin. Sci. (Lond.)"},{"key":"2021113011181144200_B13","doi-asserted-by":"publisher","first-page":"14838","DOI":"10.1074\/jbc.M200581200","article-title":"Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase","volume":"277","author":"Vickers","year":"2002","journal-title":"J. Biol. Chem."},{"key":"2021113011181144200_B14","doi-asserted-by":"publisher","first-page":"8258","DOI":"10.1073\/pnas.1432869100","article-title":"Angiotensin-(1-7) is an endogenous ligand for the G-protein coupled receptor Mas","volume":"100","author":"Santos","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021113011181144200_B15","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1152\/physrev.00023.2016","article-title":"The ACE2\/Angiotensin-(1-7)\/MAS axis of the renin-angiotensin system: focus on angiotensin-(1-7)","volume":"98","author":"Santos","year":"2018","journal-title":"Physiol. Rev."},{"key":"2021113011181144200_B16","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1042\/CS20200478","article-title":"ACE2 in the renin-angiotensin system","volume":"134","author":"Verano-Braga","year":"2020","journal-title":"Clin. Sci. (Lond.)"},{"key":"2021113011181144200_B17","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1042\/CS20200479","article-title":"Interaction between the apelinergic system and ACE2 in the cardiovascular system: therapeutic implications","volume":"134","author":"Chatterjee","year":"2020","journal-title":"Clin. Sci. (Lond.)"},{"key":"2021113011181144200_B18","article-title":"Angiotensin-converting enzyme 2 (ACE2) and COVID-19 in cardiorenal diseases","author":"Sharma","year":"2020","journal-title":"Clin. Sci. (Lond.)"},{"key":"2021113011181144200_B19","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1042\/CS20200484","article-title":"ACE2, the kidney and the emergence of COVID-19 two decades after ACE2 discovery","volume":"134","author":"Lores","year":"2020","journal-title":"Clin. Sci. (Lond.)"},{"key":"2021113011181144200_B20","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1042\/CS20200901","article-title":"Twenty years of progress in angiotensin converting enzyme 2 and its link to SARS-CoV-2 disease","volume":"134","author":"Ferrario","year":"2020","journal-title":"Clin. Sci. (Lond.)"},{"key":"2021113011181144200_B21","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1042\/CS20200922","article-title":"Correcting the imbalanced protective RAS in COVID-19 with angiotensin AT2-receptor agonists","volume":"134","author":"Steckelings","year":"2020","journal-title":"Clin. Sci. (Lond.)"},{"key":"2021113011181144200_B22","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1042\/CS20200483","article-title":"Brain angiotensin converting enzyme-2 in central cardiovascular regulation","volume":"134","author":"Mohammed","year":"2020","journal-title":"Clin. Sci. (Lond.)"},{"key":"2021113011181144200_B23","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1042\/CS20201268","article-title":"ACE2: from protection of liver disease to propagation of COVID-19","volume":"134","author":"Warner","year":"2020","journal-title":"Clin. Sci. (Lond.)"},{"key":"2021113011181144200_B24","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1042\/CS20200486","article-title":"ACE2 and skeletal muscle: implication in the era of COVID-19","volume":"134","author":"Yamamoto","year":"2020","journal-title":"Clin. Sci. (Lond.)"},{"key":"2021113011181144200_B25","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1042\/CS20200865","article-title":"Angiotensin-converting enzyme 2 (ACE2), angiotensin-(1-7) and Mas receptor in gonadal and reproductive functions","volume":"134","author":"Reis","year":"2020","journal-title":"Clin. Sci. (Lond.)"},{"key":"2021113011181144200_B26","doi-asserted-by":"publisher","first-page":"11852","DOI":"10.1021\/ja0277226","article-title":"Substrate-based design of the first class of angiotensin-converting enzyme-related carboxypeptidase (ACE2) inhibitors","volume":"124","author":"Dales","year":"2002","journal-title":"J. Am. Chem. Soc."},{"key":"2021113011181144200_B27","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1042\/CS20200570","article-title":"ACE2 as therapeutic agent","volume":"134","author":"Li","year":"2020","journal-title":"Clin. Sci. (Lond.)"},{"key":"2021113011181144200_B28","doi-asserted-by":"publisher","first-page":"e57555","DOI":"10.7554\/eLife.57555","article-title":"Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome","volume":"9","author":"van de Veerdonk","year":"2020","journal-title":"eLife"},{"key":"2021113011181144200_B29","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.cell.2020.04.004","article-title":"Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2","volume":"181","author":"Monteil","year":"2020","journal-title":"Cell"},{"key":"2021113011181144200_B30","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/S2213-2600(20)30418-5","article-title":"Human recombinant soluble ACE2 in severe COVID-19","volume":"8","author":"Zoufaly","year":"2020","journal-title":"Lancet Respir. Med."}],"container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/134\/23\/3229\/899543\/cs-2020-1493.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/134\/23\/3229\/899543\/cs-2020-1493.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T12:16:06Z","timestamp":1638274566000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/134\/23\/3229\/227256\/ACE2-a-multifunctional-protein-from-cardiovascular"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":30,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2020,12,11]]}},"URL":"https:\/\/doi.org\/10.1042\/cs20201493","relation":{},"ISSN":["0143-5221","1470-8736"],"issn-type":[{"value":"0143-5221","type":"print"},{"value":"1470-8736","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,12]]},"published":{"date-parts":[[2020,12]]}}}